Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis

BACKGROUND: The comparative efficacy and safety of PCSK9 inhibitors, statins, and ezetimibe to lower lipid levels in patients with hypercholesterolemia remain unknown. We aimed to investigate the benefits and harms of the lipid-lowering agents in these patients. METHODS: PubMed, Embase, and the Coch...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zonglei, Du, Song, Shen, Shuxin, Luo, Ping, Ding, Shoukun, Wang, Guanggong, Wang, Lixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380691/
https://www.ncbi.nlm.nih.gov/pubmed/30732185
http://dx.doi.org/10.1097/MD.0000000000014400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380691/
https://www.ncbi.nlm.nih.gov/pubmed/30732185
http://dx.doi.org/10.1097/MD.0000000000014400

Ejemplares similares